Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01181_DB06414_nanopub.RA171TCNFHZSvOON9xj-4pbsmbltjVwYfmXvosIBEY8ys#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01181_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01181_DB06414 label "DDI between Ifosfamide and Etravirine - Ifosfamide, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience an increase in the serum concentrations of its active metabolites. It is recommended to monitor for toxicity of ifosfamide therapy. [drugbank_resource:DB01181_DB06414]" assertion.
- drugbank_resource:DB01181_DB06414 identifier "drugbank_resource:DB01181_DB06414" assertion.
- drugbank_resource:DB01181_DB06414 title "DDI between Ifosfamide and Etravirine - Ifosfamide, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience an increase in the serum concentrations of its active metabolites. It is recommended to monitor for toxicity of ifosfamide therapy." assertion.
- drugbank:DB01181 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01181_DB06414 assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01181_DB06414 assertion.